Angela Richmond, MD, PhD, is a neurologist who specializes in movement disorders and the function of the nervous system. She helps patients with diagnosis, treatment and management of a range of conditions including tremor, concussion, cognitive decline, Parkinson’s disease, Huntington’s disease, dystonia and cerebellar ataxia. She is also trained in therapeutic botulinum toxin injections.

Dr. Richmond studied neuroscience because she had a family member affected by a neurodegenerative disease and saw its effects. She provides patient-centered care and treats individuals as people with medical concerns and encourages her patients to ask questions, voice their concerns and set goals.

In her personal life, Dr. Richmond is married with two children. She enjoys reading, trying new restaurants and spending time with her family and friends. A sports enthusiast, she enjoys playing, coaching and watching sports, cheering on the Missouri Tigers at every opportunity.

Education & Training

Medical School

University of Missouri School of Medicine

Graduate Institution

St. Louis University


Internal Medicine

  • University of Missouri School of Medicine GME



  • University of Missouri School of Medicine GME



  • University of Kansas Medical Center

Post-Graduate School

Washington University


American Board of Psychiatry & Neurology


MU Health Care participates with most major managed care organizations. To find out whether MU Health Care is a participating provider in your insurance plan or network, or for information on co-payments and deductibles, please contact your insurance carrier directly.

Academic Information

Assistant Professor of Neurology

Research Profile

Angela Richmond, MD, PhD, is a neurologist and movement disorders clinician and researcher interested in Parkinson’s disease, deep brain stimulation (DBS), dystonia, therapeutic botulinum toxin, Huntington’s disease and cerebellar ataxia. Her past research efforts included helping her patients participate in clinical trials to learn more about Parkinson’s disease. One trial offered free genetic testing for certain Parkinson's disease-related genes and genetic counseling for those affected with Parkinson’s disease, and the other gathered information from patients over time to learn more about how Parkinson’s disease starts and changes.

Research Interests

  • Advanced therapies for Parkinson’s disease, including infusion therapies, deep brain stimulation (DBS), magnetic resonance-guided focused ultrasound (MRg-FUS)
  • Tremor
  • Therapeutic botulinum toxin
  • Dystonia

Areas of Expertise

  • Parkinson’s disease
  • Tremor
  • Huntington’s disease
  • Dystonia
  • Cerebellar ataxia
  • Therapeutic botulinum toxin injections
  • Concussion